122 related articles for article (PubMed ID: 35818749)
41. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
[TBL] [Abstract][Full Text] [Related]
42. Incidence of lymphoproliferative disorders in patients with celiac disease.
Leslie LA; Lebwohl B; Neugut AI; Gregory Mears J; Bhagat G; Green PH
Am J Hematol; 2012 Aug; 87(8):754-9. PubMed ID: 22641457
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
Front Immunol; 2022; 13():903315. PubMed ID: 36172352
[TBL] [Abstract][Full Text] [Related]
44. Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment.
Yang X; Miyawaki T; Kanegane H
Immunotherapy; 2013 Apr; 5(4):415-25. PubMed ID: 23557424
[TBL] [Abstract][Full Text] [Related]
45. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis.
Banko A; Miljanovic D; Lazarevic I; Jeremic I; Despotovic A; Grk M; Cirkovic A
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062319
[TBL] [Abstract][Full Text] [Related]
46. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T
Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
Shirin H; Davidovitz Y; Avni Y; Petchenko P; Krepel Z; Bruck R; Meytes D
Isr Med Assoc J; 2002 Jan; 4(1):24-7. PubMed ID: 11802304
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience.
Rogers BB; Sommerauer J; Quan A; Timmons CF; Dawson DB; Scheuermann RH; Krisher K; Atkins C
Pediatr Dev Pathol; 1998; 1(6):480-6. PubMed ID: 9724334
[TBL] [Abstract][Full Text] [Related]
51. [Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Tokuhira M; Kizaki M
Rinsho Ketsueki; 2019; 60(8):932-943. PubMed ID: 31484893
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
53. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation.
Lucas KG; Burton RL; Zimmerman SE; Wang J; Cornetta KG; Robertson KA; Lee CH; Emanuel DJ
Blood; 1998 May; 91(10):3654-61. PubMed ID: 9573001
[TBL] [Abstract][Full Text] [Related]
54. [Tuberculosis in patients with lymphoproliferative diseases].
Al-Radi LS; Moiseeva TN; Chernova NG; Sharkunov NN; Margolin OV; Shitareva IV; Baryakh EA; Klyasova GA; Roshchina LS; Kostina IE; Kravchenko SK; Pivnik AV; Vorobiov AI
Ter Arkh; 2014; 86(11):42-9. PubMed ID: 25715486
[TBL] [Abstract][Full Text] [Related]
55. Long-term prognosis of breast cancer detected by mammography screening or other methods.
Lehtimäki T; Lundin M; Linder N; Sihto H; Holli K; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H; Lundin J
Breast Cancer Res; 2011; 13(6):R134. PubMed ID: 22204661
[TBL] [Abstract][Full Text] [Related]
56. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
[TBL] [Abstract][Full Text] [Related]
57. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies.
García-Suárez J; de Miguel D; Krsnik I; Bañas H; Arribas I; Burgaleta C
Am J Hematol; 2005 Dec; 80(4):271-81. PubMed ID: 16315252
[TBL] [Abstract][Full Text] [Related]
58. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
59. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.
Bland KI; Scott-Conner CE; Menck H; Winchester DP
J Am Coll Surg; 1999 Jun; 188(6):586-95; discussion 595-6. PubMed ID: 10359351
[TBL] [Abstract][Full Text] [Related]
60. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]